NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Websites offer “poor quality” cholesterol-lowering drugs
Fri February 3rd - Patients are being warned against buying statins via the internet because of their poor quality and lack of information about how to use the medicine. More
New hope for universal vaccine for influenza
Fri February 3rd - Chemicals found inside flu viruses could pave the way for the development of a universal vaccine for the infection. More
Resistant TB spreading - WHO
Fri February 3rd - The world is facing a serious threat from the spread of hard to treat TB, experts warned yesterday. More
THIS WEEK'S STORIES
Row over new extra time drug ban
Thurs February 2nd - A row broke out today over proposals to restrict a drug for male cancer that was discovered in the UK. More
Cold hands syndrome campaign
Thurs February 2nd - Doctors have urged people with persistently cold hands to recognise the weather may not be to blame. More
Treat adolescent depression signs - professor
Thurs February 2nd - A British expert today calls for more to be done to identify and treat young people with low levels of depression. More
New tomato prostate cancer link
Wed February 1st - British researchers have made new discoveries showing how the redness in tomatoes may protect men against cancer, it was announced yesterday. More
Exercise benefits for cancer patients
Wed February 1st - Cancer patients can benefit from taking exercise after their treatment is complete, researchers say today. More
Asthma test and national review aim to cut deaths
Wed February 1st - Experts have developed a new test to give people with asthma an idea of their risk of a severe attack, it was announced today. More
ENGLEMED HEALTH NEWS

Alcohol threat to cancer battle success

Monday November 30th, 2009

Growing rates of alcohol drinking are putting at risk successes in the battle against cancer, according to a new European study.

Researchers said the European Union has seen significant drops in death rates from cancer - of more than eight per cent between 1990 and 2004.

But countries where alcohol and tobacco use is increasing, especially among women, are seeing increasing deaths from related cancers.

The report, published today by the Annals of Oncology, show high rates of cancer of the gullet - the oesophagus - in England, Wales and Scotland.

And Scotland has the third highest death rate for all cancers for women - ranked only below Denmark and Hungary. At more than 123 deaths per 100,000 women, the death rate is 50 per cent greater than Spain, Greece and Portugal.

The analysis involved some 27 countries that were members of the European Union during the period.

And as the research showed increasing death rates from skin cancer in Europe, British campaigners called for fresh restrictions on the use of sun-beds.

Dr Cristina Bosetti, of the Mario Negri Department of Epidemiology, University of Milan, Italy, said: "The key message of our paper is that the favourable trends in cancer mortality in Europe have continued over the most recent years. This is due mainly to the falls in lung and other tobacco-related cancers in men, the persistent decline in gastric cancer, but also appreciable falls in colorectal cancer.

"Screening and early diagnosis have contributed to the decline in cervical and breast cancer, although the fall in breast cancer mortality is mainly due to improved treatment. Therapeutic advancements have also played a role in the reduced mortality from testicular cancer, Hodgkin lymphoma and leukaemias, although the declines have been delayed and are smaller in eastern Europe."

* In Britain Cancer Research UK today steps up pressure on the government to ban young people under the age of 18 from using sun-beds. A ban comes into force in Scotland today.

Sarah Woolnough, of Cancer Research UK, said: "Not only are sun-beds now classified in the highest risk category for cancer, alongside tobacco, but there's also strong scientific evidence to show the damage they cause to the skin - both increasing skin cancer risk and ageing the skin.

"Using sun-beds has no general health benefits. In fact the intensity of UV rays in some sun-beds can be more than 10 times stronger than the mid-day sun."

* A second European study published today shows an "enormous" increase in the use of implantable devices for heart failure - with Britain lagging behind the rest of Europe.

Since 2004, the number of operations has nearly doubled in 15 western European countries, according to an analysis in the European Journal of Heart Failure.

Germany has the highest rate of implants, nearly four times Britain's rate, researchers found. In Germany some 264 procedures are carried out for every million people - while in Britain it is just 74. Only Spain and Portugal carried out fewer operations than Britain.

Researcher Professor Dirk van Veldhuisen, from the University of Groningen, Holland, said: "It is difficult to speculate why we see such a low rate of use in countries like Spain or UK. However, while some studies have found an added benefit from device therapy in heart failure, others have not - and we still have no clear cost-benefit analysis of their more widespread use.

"Certainly, implantable devices are expensive, and, if we follow the guidelines, the cost implications will be substantial."

Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Annals of Oncology. doi:10.1093/annonc/mdp530

Van Veldhuisen DJ, Maass AH, Priori SG, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009; doi:10.1093/eurjhf/hfp149.

Tags: Cancer | Dermatology | Drug and Alcohol Abuse | Europe | Heart Health | UK News

Printer friendly page Printer friendly page

CATEGORIES